Synopsys AI Stock Analysis
Want to see SNPS full AI Analyst Report?
Synopsys (SNPS) AI Stock Analysis
Synopsys
(NASDAQ:SNPS)
Synopsys scores moderately above average. The core strengths are exceptional cash generation ($2.79B free cash flow, well above reported earnings), continued revenue growth, 72%+ gross margins, and an encouraging earnings call featuring a guidance raise and ahead-of-schedule Ansys synergies. Technical momentum is constructive with the stock above all major moving averages, though indicators show it is stretched after a strong run. The main drags are a demanding 85x P/E with no dividend, sharply compressed GAAP margins and a 1.5% return on equity, plus a balance sheet that has moved from near debt-free to roughly $10.8B of borrowings. The investment case now rests on management converting Ansys synergies into restored margins and continued deleveraging.
Synopsys Key Performance Indicators (KPIs)
Operating Income by SegmentShows profit generated from different business units, highlighting which segments drive profitability and where there might be challenges or opportunities.
Design Automation’s operating income jumps markedly from 2025 onward, indicating EDA is shouldering Synopsys’ profit growth—consistent with management’s commentary on AI-driven demand, advanced-node wins and early ANSYS synergy benefits that underpin raised margins and guidance. Design IP is volatile, with a pronounced one‑time spike followed by a steep pullback, matching the call’s note of YoY IP weakness despite sequential recovery. Software Integrity’s persistent zeroes point to reclassification/divestiture or absorption, which reduces segment transparency and concentrates execution risk in EDA/ANSYS integration.
Synopsys (SNPS) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $87.23B
- Dividend Yield
- ―
- Average Volume (3M)
- 2.14M
- Price to Earnings (P/E)
- 79.0
- Beta (1Y)
- 1.48
- Revenue Growth
- 46.33%
- EPS Growth
- -55.91%
- Country
- US
- Employees
- 28,000
- Sector
- Technology
- Sector Strength
- 61
- Industry
- Software - Infrastructure
Synopsys Business Overview & Revenue Model
Company Description
Synopsys, Inc. is a leading provider of electronic design automation (EDA) software, instrumental in the creation and validation of integrated circuits. The company offers a robust portfolio of platforms, including the Fusion Design Platform for digi...
How the Company Makes Money
Synopsys primarily makes money by selling and licensing mission-critical engineering products used in chip and system design, plus related maintenance and professional services. 1) EDA software and hardware (tool licensing + support) - Term and subsc...
Synopsys Earnings Call Summary
The call was broadly positive: the company reported strong Q3 results with revenue up ~42% YoY, non-GAAP margin and EPS beating guidance, significant cash generation, ahead-of-schedule synergy realization, and raised full-year guidance. Strategic milestones — the Ansys integration anniversary, the Multiphysics Fusion launch, agentic AI demonstrations, robust EDA momentum and notable IP wins — underpin confidence in multi-year growth. Near-term headwinds include a large absolute debt balance (~$10B), increased restructuring/GAAP charges, a modest backlog decline tied to a divestiture, and the expectation that some new product-driven revenue (e.g., Multiphysics Fusion) will contribute meaningfully only beginning in 2027. Overall, the positive operational execution, guidance raise and pipeline momentum outweigh the limited near-term negatives.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Synopsys raised its fiscal 2026 outlook, guiding total revenue to $9.69–$9.74 billion (midpoint +$50M) with Ansys revenue ~ $2.98 billion (up $20M); total GAAP costs/expenses $8.667–$8.742 billion and total non‑GAAP costs/expenses $5.67–$5.70 billion, implying a non‑GAAP operating margin of 41.5% at the midpoint (up 50 bps). GAAP EPS is forecast at $3.84–$4.08 and non‑GAAP EPS at $15.04–$15.10 (midpoint +$0.31); cash from operations was raised to ~ $2.8 billion (up $500M), CapEx trimmed to ~$225 million and free cash flow is expected to be ~ $2.6 billion (up $600M). For Q4 they guide revenue of $2.53–$2.58 billion, GAAP costs $2.225–$2.30 billion, non‑GAAP costs $1.45–$1.48 billion, GAAP EPS $0.60–$0.85 and non‑GAAP EPS $4.10–$4.16, and they expect double‑digit organic EDA growth in Q4 and for the full year with sequential IP growth in Q4.
Synopsys Financial Statement Overview
Summary
Composite of the Income Statement (63), Balance Sheet (66) and Cash Flow (79) scores. Revenue continues to grow (TTM $9.42B, +8.5%, after three straight years of ~15% growth) and gross margin remains strong at 72.4%, while free cash flow of $2.79B (~30% of revenue, ~94% conversion) comfortably exceeds reported net income — confirming that the sharp drop in operating margin (11.7% vs. 25-26% prior) and net margin (4.8%) is largely driven by non-cash Ansys amortization and integration charges rather than business deterioration. Offsetting this, the balance sheet is far more levered than historically ($10.8B debt vs. $684M a year earlier), equity is heavily weighted toward goodwill and intangibles, and return on equity has collapsed to 1.5%. Leverage is already improving (D/E 0.35 from 0.50), but the score reflects a genuine transition year where margin recovery still has to be demonstrated.
Income Statement
63PositiveBalance Sheet
66PositiveCash Flow
79Positive| Breakdown | TTM | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.42B | 7.05B | 6.13B | 5.32B | 4.62B | 4.20B |
| Gross Profit | 6.82B | 5.43B | 4.88B | 4.29B | 3.72B | 3.34B |
| EBITDA | 3.73B | 2.50B | 1.85B | 1.56B | 1.33B | 1.01B |
| Net Income | 1.08B | 1.33B | 2.26B | 1.23B | 984.59M | 757.52M |
Balance Sheet | ||||||
| Total Assets | 47.73B | 48.22B | 13.07B | 10.33B | 9.42B | 8.75B |
| Cash, Cash Equivalents and Short-Term Investments | 3.61B | 2.96B | 4.05B | 1.59B | 1.57B | 1.58B |
| Total Debt | 10.84B | 14.29B | 684.46M | 677.60M | 656.37M | 666.77M |
| Total Liabilities | 16.57B | 19.90B | 4.05B | 4.15B | 3.86B | 3.45B |
| Stockholders Equity | 31.15B | 28.33B | 8.99B | 6.15B | 5.52B | 5.30B |
Cash Flow | ||||||
| Free Cash Flow | 2.79B | 1.35B | 1.28B | 1.51B | 1.60B | 1.40B |
| Operating Cash Flow | 2.98B | 1.52B | 1.41B | 1.70B | 1.74B | 1.49B |
| Investing Cash Flow | 918.62M | -15.91B | 1.22B | -482.10M | -572.62M | -549.03M |
| Financing Cash Flow | -2.59B | 13.39B | -181.30M | -1.20B | -1.12B | -748.75M |
Synopsys Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SNPS, the sentiment is Positive. The current price of 455.20 is below the 20-day moving average (MA) of 458.20, above the 50-day MA of 445.16, and above the 200-day MA of 441.09, indicating a neutral trend. The MACD of 1.51 indicates Positive momentum. The RSI at 48.70 is Neutral, neither overbought nor oversold. The STOCH value of 58.97 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SNPS.
Synopsys Risk Analysis
Synopsys disclosed 29 risk factors in its most recent earnings report. Synopsys reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
3 New RisksSynopsys Peers Comparison
Overall Rating
CRWD77Outperform
FTNT73Outperform
PANW69Neutral
SNPS68Neutral
TENB64Neutral
SABR57Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | $232.03B | 6437.78 | 1.29% | ― | 24.30% | ― | |
| 73Outperform | $93.47B | 41.04 | 151.52% | ― | 20.23% | 26.26% | |
| 69Neutral | $263.84B | 700.52 | 1.68% | ― | 24.49% | -68.55% | |
| 68Neutral | $87.23B | 79.03 | 3.57% | ― | 46.33% | -55.91% | |
| 64Neutral | $4.26B | 283.45 | 8.46% | ― | 9.53% | ― | |
| Sector * | 61Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
| 57Neutral | $751.05M | -4.78 | 14.73% | ― | -0.57% | -128.24% |
* Technology Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SNPS | Synopsys | 455.20 | 64.96 | 16.65% | |
| FTNT | Fortinet | 127.22 | 45.28 | 55.26% | |
| PANW | Palo Alto Networks | 322.24 | 119.34 | 58.82% | |
| SABR | Sabre Corp | 1.86 | 0.17 | 10.06% | |
| TENB | Tenable Holdings | 40.76 | 14.70 | 56.41% | |
| CRWD | Crowdstrike Holdings | 226.61 | 94.17 | 71.10% |
Synopsys Corporate Events
Synopsys Launches $1 Billion Accelerated Share Repurchase
PositiveOn Oct. 5, 2026, Synopsys announced it had entered into an accelerated share repurchase agreement with JPMorgan Chase Bank, National Association to buy back $1 billion of its common stock. Under the terms of the ASR, Synopsys is set to receive an ini...
Synopsys Announces Transition of General Counsel Role
NeutralOn August 12, 2026, Synopsys, Inc. announced that Janet Lee will step down as General Counsel and Corporate Secretary, effective on the earlier of December 31, 2026, or the appointment of her successor. The company said she will then move into an adv...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 05, 2026
